Conditions: Non Small Cell Lung Cancer; Lung Cancer; Breast Cancer; Esophageal Cancer; Small Cell Lung Cancer; Nasopharyngeal Cancer; Head and Neck Squamous Cell Carcinoma; Prostate Adenocarcinoma; Ovarian Cancer; Endometrial Cancer; Cervical Cancer; Triple Negative Breast Cancer
Interventions: Drug: BL-B01D1
Sponsors: SystImmune Inc.
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
